Entrada jumped over 30% in morning trading,above its IPO price at 20 dollars per share<blockquote>Entrada 早盘交易中股价上涨超过 30%，高于每股 20 美元的 IPO 价格</blockquote>
Entrada jumped over 30% in morning trading,above its IPO price at 20 dollars per share.Entrada, which is working to develop therapeutics for rare neuromuscular diseases such as Duchenne muscular dystrophy and myotonic dystrophy type 1, said it believes the proceeds, coupled with its existing resources, will be sufficient to fund its operating expenses and capital-spending needs into the second quarter of 2024.